Loading stock data...
Last Updated: 10 Mar 2026, 03:14:21 PM (IST)

Kimia Biosciences Ltd.

BSE: KIMIABL

BSE
31.35 1.20 (3.98%)

Prev Close

30.15

Open Price

31

Volume

588

Today Low / High

30 / 31.89

52 WK Low / High

26.09 / 86.85

Range

30 - 33

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 31.35, reflecting a change of 1.2 (3.9801%). The expected target range on the BSE is 30 - 33. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

Kimia Biosciences Ltd. Graph

Kimia Biosciences Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Kimia Biosciences Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 31.35, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 31.35 31.66 28.50 - 34.83
31.98 25.58 - 38.37
32.29 22.60 - 41.98
Bearish Scenario 31.35 31.04 27.93 - 34.14
30.72 24.58 - 36.87
30.41 21.29 - 39.53

Overview of Kimia Biosciences Ltd.

ISIN

INE285U01025

Industry

Medical - Pharmaceuticals

Vol.Avg

9,993

Market Cap

1,593,966,244

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

39.96

DCF

-7

Financial Ratios Every Investor Needs

Stock Rating Details for KIMIABL

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 118.44 Cr 94.76 Cr 23.69 Cr 0.2000 0.00 Cr 0.00 Cr 16.39 Cr 9.61 Cr 2.03 21.05 Cr 0.0812
2024-03-31 104.88 Cr 100.86 Cr 4.02 Cr 0.0383 5.02 Cr 0.00 Cr -4.23 Cr -5.31 Cr -1.12 0.68 Cr -0.0506
2023-03-31 128.14 Cr 126.02 Cr 2.12 Cr 0.0165 0.00 Cr 0.00 Cr -7.15 Cr -9.35 Cr -1.98 -4.81 Cr -0.0730
2022-03-31 124.63 Cr 119.77 Cr 4.86 Cr 0.0390 6.38 Cr 0.00 Cr -2.51 Cr -3.70 Cr -0.78 1.56 Cr -0.0297
2021-03-31 132.71 Cr 120.95 Cr 11.76 Cr 0.0886 6.16 Cr 0.00 Cr 6.47 Cr 5.10 Cr 1.08 10.84 Cr 0.0385

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.21 Cr 113.32 Cr 103.36 Cr 9.9661 Cr 39.36 Cr 39.15 Cr 35.91 Cr 31.34 Cr 3.79 Cr 0.85 Cr 0.00 Cr 81.8250 Cr
2024-03-31 0.53 Cr 99.97 Cr 99.64 Cr 0.3310 Cr 43.71 Cr 43.17 Cr 31.43 Cr 32.38 Cr 0.00 Cr 1.35 Cr 0.26 Cr 69.4377 Cr
2023-03-31 0.50 Cr 123.19 Cr 117.72 Cr 5.4628 Cr 52.92 Cr 52.42 Cr 48.55 Cr 34.19 Cr 2.31 Cr 1.85 Cr 0.00 Cr 76.3978 Cr
2022-03-31 0.52 Cr 111.06 Cr 96.18 Cr 14.8883 Cr 45.50 Cr 44.99 Cr 37.23 Cr 35.08 Cr 1.70 Cr 2.35 Cr 0.00 Cr 61.8018 Cr
2021-03-31 1.67 Cr 107.42 Cr 88.99 Cr 18.4364 Cr 49.41 Cr 47.74 Cr 23.92 Cr 34.53 Cr 0.61 Cr 2.85 Cr 0.00 Cr 50.9482 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 15.4245 Cr -4.6873 Cr -10.6787 Cr 10.8253 Cr 0.0585 Cr 0.2061 Cr -4.5992 Cr 9.6124 Cr -10.6787 Cr 0.0000 Cr -3.7796 Cr
2024-03-31 10.6913 Cr -1.5093 Cr -9.2121 Cr 9.4903 Cr -0.3509 Cr 0.5344 Cr -1.5067 Cr -5.3087 Cr -9.2121 Cr 0.0000 Cr 17.4303 Cr
2023-03-31 -9.5104 Cr -2.8204 Cr 12.3036 Cr -12.3224 Cr -0.0188 Cr 0.4985 Cr -2.8120 Cr -9.3522 Cr 12.3036 Cr 0.0000 Cr -11.2157 Cr
2022-03-31 4.6708 Cr -0.7382 Cr -1.0721 Cr 1.0910 Cr -1.1566 Cr 0.5173 Cr -3.5798 Cr -3.7030 Cr -1.0721 Cr 0.0000 Cr -13.3310 Cr
2021-03-31 3.5421 Cr -13.6563 Cr 10.4690 Cr -10.0186 Cr 0.9007 Cr 1.6739 Cr -13.5607 Cr 5.1044 Cr 10.4690 Cr 0.0000 Cr -3.3749 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 30.10 Cr 20.31 Cr 9.79 Cr 0.3252 5.70 Cr 5.44 Cr 1.15 6.55 Cr 0.1808
2025-09-30 34.00 Cr 26.74 Cr 7.26 Cr 0.2136 1.55 Cr 1.02 Cr 0.21 2.19 Cr 0.0299
2025-06-30 23.58 Cr 18.37 Cr 5.21 Cr 0.2211 1.59 Cr 0.60 Cr 0.13 3.37 Cr 0.0256
2025-03-31 38.24 Cr 28.09 Cr 10.15 Cr 0.2654 7.30 Cr 1.99 Cr 0.42 8.62 Cr 0.0521
2024-12-31 29.62 Cr 21.71 Cr 8.39 Cr 0.2831 4.18 Cr 4.57 Cr 0.97 5.42 Cr 0.1543

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.21 Cr 0.50 Cr 0.71 Cr 28.18 Cr 34.65 Cr 65.50 Cr 29.89 Cr 101.49 Cr 89.91 Cr
2025-03-31 0.21 Cr 0.47 Cr 0.68 Cr 37.66 Cr 35.91 Cr 75.29 Cr 31.34 Cr 113.32 Cr 103.36 Cr
2024-12-31 0.18 Cr 0.44 Cr 0.63 Cr 30.38 Cr 31.31 Cr 65.12 Cr 30.19 Cr 101.85 Cr 93.90 Cr
2024-09-30 0.33 Cr 0.44 Cr 0.78 Cr 24.96 Cr 33.68 Cr 61.76 Cr 31.01 Cr 98.92 Cr 95.54 Cr
2024-03-31 0.53 Cr 0.00 Cr 0.53 Cr 28.29 Cr 30.80 Cr 61.41 Cr 32.38 Cr 99.97 Cr 99.64 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 -1.95 Cr 1.64 Cr 0.00 Cr 0.00 Cr 1.64 Cr 2.22 Cr 0.58 Cr 0.00 Cr 1.64 Cr
2023-09-30 -2.44 Cr -2.44 Cr 0.00 Cr 0.00 Cr -2.44 Cr 0.58 Cr 3.02 Cr 0.00 Cr -2.44 Cr
2023-06-30 -2.71 Cr -2.71 Cr 0.00 Cr 0.00 Cr -3.21 Cr -2.71 Cr 0.50 Cr 0.00 Cr -2.71 Cr
2023-03-31 -6.17 Cr -6.17 Cr 0.00 Cr 0.00 Cr -6.17 Cr 0.50 Cr 6.66 Cr 0.00 Cr -6.17 Cr
2022-12-31 -3.46 Cr -3.46 Cr 0.00 Cr 0.00 Cr -4.07 Cr -3.46 Cr 0.61 Cr 0.00 Cr -3.46 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹830.35 ₹99,644,807,413.00 ₹76,499.00

Key Executives

Head of Research & Development
Mukesh Kumar Sharma

Gender: Not Specified

Year Born: 1968

Advisor of Strategy & IPR Head of Intellectual Property Rights
Rita Sarin

Gender: Not Specified

Year Born:

AGM of Corporate Strategy & Sustainability
Krishan Kant

Gender: Not Specified

Year Born: 1997

Assistant General Manager of Finance & Accounts
Mathura Datt Joshi

Gender: male

Year Born: 1973

Chief Financial Officer
Pradip Kumar Sharma

Gender: male

Year Born:

Chief Executive Officer, Chairman of the Board & MD
Sameer Goel

Gender: male

Year Born: 1975

Company Secretary & Compliance Officer
Pallavi Garg

Gender: female

Year Born:

Chief Operating Officer
Subrat Satpathy

Gender: Not Specified

Year Born: 1975

Manager of Marketing
Ruchita Gopal Mishra

Gender: Not Specified

Year Born: 1990

Chief Human Resources Officer
Asit Tanaji Bhalerao

Gender: Not Specified

Year Born: 1982

FAQs about Kimia Biosciences Ltd.

Who is the CEO of the company?

The CEO is Sameer Goel.

What is the current market price of the stock?

The current price is ₹33.69.

What is the 52-week price range?

The range is ₹26.09-86.85.

What is the market capitalization of the company?

The market capitalization is ₹159.40 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 17.61.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Kimia Biosciences Ltd. (ISIN: INE285U01025) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹159.40 crores and an average daily volume of 9,993 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.